We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

23 hedge funds and large institutions have $30.3M invested in Apollo Endosurgery, Inc. in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 14 (+3)

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

59% more capital invested

Capital invested by funds: $19.1M → $30.3M (+$11.2M)

15% more funds holding

Funds holding: 2023 (+3)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

Holders
23
Holders Change
+3
Holders Change %
+15%
% of All Funds
0.52%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.09%
New
8
Increased
4
Reduced
5
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
26
Millennium Management
New York
-$54K -11,589 Closed
Northwestern Mutual Wealth Management
27
Northwestern Mutual Wealth Management
Wisconsin
+$55 +12 New

APEN Hedge Fund Activity: Q4 2017 in Review

23 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q4 2017, worth a combined $30.3M — up 59% from $19.1M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new APEN positions and 5 closed out — a net gain of 3 holders — while 4 added to existing stakes and 5 trimmed.

The largest buyer was Stonepine Capital Management, adding an estimated $891K. The largest seller was Novo Holdings A/S, exiting entirely with an estimated $1.28M sold.

  • 23 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q4 2017, up from 20 in Q3 2017.
  • Funds reported $30.3M of Apollo Endosurgery, Inc. stock for Q4 2017, up 59% quarter-over-quarter.
  • 8 funds opened new Apollo Endosurgery, Inc. positions in Q4 2017 and 5 closed out, a net change of +3 holders.
  • The largest Apollo Endosurgery, Inc. buyer in Q4 2017 was Stonepine Capital Management, an estimated $891K added.
  • The largest Apollo Endosurgery, Inc. seller in Q4 2017 was Novo Holdings A/S, an estimated $1.28M sold.

Based on aggregated 13F filings for Q4 2017.